House Subcommittee Considers More Than 20 Bills Related to Innovation
The House Subcommittee on Energy and Trade on Health held a legislative hearing on March 17 to consider 22 bills related to medical innovation, oversight by the Food and Drug Administration (FDA) and a variety of clinical trials. The hearing took place at a time when the subcommittee is drafting legislation to re-authorize FDA user … Read more